11 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 9.9% per year over the past 5 years.
Net income has grown slower than revenue (-23.2% vs 9.9% per year).
Financial health
Total debt ($532M) exceeds cash ($3M); net debt is $529M.
Total debt has grown faster than revenue (20.2% vs 9.9% per year).
Shareholder returns
Dividends have been paid for 11 consecutive years, consuming 1051.9% of earnings.
The dividend has grown 7.1% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$121M
$5M
0.0%
0.0%
—
$532M
$3M
2024
$116M
-$3M
0.0%
0.0%
—
$486M
$4M
2023
$113M
$8M
0.0%
0.0%
—
$403M
$3M
2022
$98M
$22M
0.0%
0.0%
—
$353M
$11M
2021
$91M
$22M
0.0%
0.0%
—
$266M
$2M
2020
$76M
$19M
0.0%
0.0%
—
$212M
$2M
2019
$61M
$8M
0.0%
0.0%
—
$194M
$2M
2018
$49M
$4M
0.0%
0.0%
—
$148M
$2M
2017
$37M
$4M
0.0%
0.0%
—
$93M
$2M
2016
$25M
$3M
0.0%
0.0%
—
$51M
$2M
2015
—
-$1M
—
—
—
—
$2M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$32M
$3M
0.0%
0.0%
—
$559M
$3M
Dec '25
$31M
$14M
0.0%
0.0%
—
$532M
$3M
Sep '25
$31M
$2M
0.0%
0.0%
—
$530M
$3M
Jun '25
$29M
-$13M
0.0%
0.0%
—
$500M
$5M
Mar '25
$30M
$2M
0.0%
0.0%
—
$496M
$2M
Dec '24
$29M
$2M
0.0%
0.0%
—
$486M
$4M
Sep '24
$30M
$2M
0.0%
0.0%
—
$474M
$3M
Jun '24
$28M
-$10M
0.0%
0.0%
—
$458M
$734000
Mar '24
$29M
$4M
0.0%
0.0%
—
$442M
$4M
Dec '23
$29M
$5M
0.0%
0.0%
—
$403M
$3M
Sep '23
$29M
$3M
0.0%
0.0%
—
$401M
$4M
Jun '23
$28M
$7M
0.0%
0.0%
—
$368M
$3M
Mar '23
$27M
-$7M
0.0%
0.0%
—
$365M
$4M
Dec '22
$25M
$5M
0.0%
0.0%
—
$353M
$11M
Sep '22
$25M
$6M
0.0%
0.0%
—
$311M
$3M
Jun '22
$24M
$6M
0.0%
0.0%
—
$292M
$2M
Mar '22
$23M
$6M
0.0%
0.0%
—
$270M
$1M
Dec '21
$23M
$6M
0.0%
0.0%
—
$266M
$2M
Sep '21
$23M
$5M
0.0%
0.0%
—
$258M
$2M
Jun '21
$23M
$6M
0.0%
0.0%
—
$259M
$5M
Valuation over time
How the market has priced CHCT against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 47.5× (Mar '23) to 100.7× (Jun '26).
The price-to-sales ratio has fallen from 10.7× (Mar '23) to 4.2× (Jun '26).
The dividend yield has risen from 4.3% (Mar '23) to 10.4% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is CHCT growing its revenue and profit?
Over the past 5 years, Community Healthcare Trust Inc's revenue has grown 9.9% per year, and net income declined 23.2% per year. These are computed facts, not advice.
How much debt does CHCT have?
As of FY2025, Community Healthcare Trust Inc reported $532M of total debt against $3M of cash.
What is CHCT's profit margin?
In FY2025, gross margin was —, operating margin —, and net margin 4.2%.
What is CHCT's P/E ratio?
As of Jun '26, Community Healthcare Trust Inc traded at a price-to-earnings ratio of about 100.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.